Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 7/20 | 0.81 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.81 |
| ▸ | NPC1 | O15118 | 5/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.81 |
| ▸ | MEN1 | O00255 | 4/20 | 0.81 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.78 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.78 |
| ▸ | ESRRG | P62508 | 2/20 | 0.73 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.73 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.73 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.73 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.71 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | PKM | P14618 | 1/20 | 0.71 |
| ▸ | CA1 | P00915 | 1/20 | 0.69 |
| ▸ | CA2 | P00918 | 1/20 | 0.69 |
| ▸ | CA4 | P22748 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL711755 | 1.00 | RAB9A (0.81) | RAB9ASMN1; SMN2NPC1KMT2AMEN1 | |
| SCHEMBL2830919 | 1.00 | RAB9A (0.81) | RAB9ASMN1; SMN2NPC1KMT2AMEN1 | |
| SCHEMBL6720187 | 0.96 | RAB9A (0.87) | RAB9ASMN1; SMN2NPC1KMT2AMEN1 | |
| SCHEMBL13568982 | 0.96 | RAB9A (0.87) | RAB9ASMN1; SMN2NPC1KMT2AMEN1 | |
| SCHEMBL13568878 | 0.91 | RAB9A (0.97) | RAB9ASMN1; SMN2NPC1KMT2AMEN1 | |
| SCHEMBL8767795 | 0.91 | HDAC3 (0.72) | RAB9ASMN1; SMN2NPC1KMT2AMEN1 | |
| SCHEMBL12305537 | 0.91 | RAB9A (0.73) | RAB9ASMN1; SMN2NPC1KMT2AMEN1 | |
| SCHEMBL20115425 | 0.90 | RAB9A (1.00) | RAB9ASMN1; SMN2NPC1KMT2AMEN1 | |
| SCHEMBL8253424 | 0.90 | RAB9A (0.77) | RAB9ASMN1; SMN2NPC1KMT2AMEN1 | |
| SCHEMBL21292680 | 0.90 | RAB9A (1.00) | RAB9ASMN1; SMN2NPC1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4580403-A2 | APYRASE INHIBITORS | Texas Crop Science, Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| CN-120166922-A | Apyrase inhibitors | 德州作物科学股份有限公司 | 2025-06-17 | — | — | CN | claimed |
| US-12031058-B2 | Corrosion inhibition compositions and associated methods for inhibiting corrosion on metallic substrates | THE BOEING COMPANY (US) | 2024-07-09 | — | — | US | claimed |
| US-20240101510-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE, INC. | 2024-03-28 | — | — | US | claimed |
| WO-2024050040-A2 | APYRASE INHIBITORS | TEXAS CROP SCIENCE (US) | 2024-03-07 | — | — | WO | claimed |
| US-20230052367-A1 | CORROSION INHIBITION COMPOSITIONS AND ASSOCIATED METHODS FOR INHIBITING CORROSION ON METALLIC SUBSTRATES | THE BOEING COMPANY (US) | 2023-02-16 | — | — | US | claimed |
| EP-4112776-A1 | CORROSION INHIBITION COMPOSITIONS AND ASSOCIATED METHODS FOR INHIBITING CORROSION ON METALLIC SUBSTRATES | The Boeing Company (US) | 2023-01-04 | — | — | EP | claimed |
| US-20240352260-A1 | CORROSION INHIBITION COMPOSITIONS AND ASSOCIATED METHODS FOR INHIBITING CORROSION ON METALLIC SUBSTRATES | THE BOEING COMPANY (US) | 2024-10-24 | — | — | US | disclosed |
| US-12031058-B2 | Corrosion inhibition compositions and associated methods for inhibiting corrosion on metallic substrates | THE BOEING COMPANY (US) | 2024-07-09 | — | — | US | disclosed |
| US-12031058-B2 | Corrosion inhibition compositions and associated methods for inhibiting corrosion on metallic substrates | THE BOEING COMPANY (US) | 2024-07-09 | — | — | US | disclosed |
| US-12031058-B2 | Corrosion inhibition compositions and associated methods for inhibiting corrosion on metallic substrates | THE BOEING COMPANY (US) | 2024-07-09 | — | — | US | disclosed |
| US-20240101510-A1 | APYRASE INHIBITORS | TEXAS CROP SCIENCE, INC. | 2024-03-28 | — | — | US | disclosed |
| US-11813596-B2 | Photocatalytic system and applications thereof | Max Planck Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2023-11-14 | — | — | US | disclosed |
| US-6506849-B1 | Natural or synthetic rubber; maleimide compound; and polyaniline, hydrazide and/or amine compound; workability, elasticity | BRIDGESTONE CORPORATION (JP) | 2003-01-14 | — | — | US | disclosed |
| US-20020049294-A1 | Rubber composition and heavy duty pneumatic tire using the rubber composition | BRIDGESTONE CORPORATION | 2002-04-25 | — | — | US | disclosed |
| EP-1184412-A1 | Rubber composition and heavy duty pneumetic tire using the rubber composition | Bridgestone Corporation (JP) | 2002-03-06 | — | — | EP | disclosed |
| US-5633356-A | RADIOACTIVE INTERMEDIATE METABOLITE FOR USE IN DIAGNOSTIC TESTING | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1997-05-27 | — | — | US | disclosed |
| US-5623063-A | USING CARBON ISOTOPE-LABELLED GLUCOSE AS STARTING MATERIAL | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1997-04-22 | — | — | US | disclosed |
| US-5618734-A | USING A LABELLED CARBON COMPOUND AS AN INTERNAL STANDARD; USEFUL IN DIAGNOSING DIABETES AND KIDNEY DISEASES | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1997-04-08 | — | — | US | disclosed |
| EP-0645625-A1 | 3-Deoxyglucosone derivatives and method for determining the same | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-03-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11813596-B2 | Photocatalytic system and applications thereof | HCCS, CRY1, PCBP1 | RAB9A 4237/4885SMN1; SMN2 3933/4885NPC1 4777/4885 |
| US-20240101510-A1 | APYRASE INHIBITORS | APEH, DPEP1, PON1 | RAB9A 1387/4885SMN1; SMN2 4511/4885NPC1 2564/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.